Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
The Walt Disney Co. (NYSE: DIS) reported fiscal second-quarter financial results after the markets closed on Tuesday. The company had $1.36 in earnings per share (EPS) on $12.97 billion in revenue compared to consensus…
Electronic Arts Inc. (NASDAQ: EA) released its fiscal fourth-quarter earnings report after the markets closed on Tuesday. The company has $0.50 in earnings per share (EPS) on $924 million in revenue versus Thomson Reuters…
Macy’s is set to report its fiscal first-quarter financial results before the markets open on Wednesday.
Electronic Arts is scheduled to release its fiscal fourth-quarter earnings report after the markets close on Tuesday.
Anacor Pharmaceuticals reported its first-quarter financial results before the markets opened on Tuesday.
SolarEdge Technologies reported better-than-expected fiscal third-quarter financial results after the markets closed on Monday.
The SEC had announced fraud charges against a Pittsburgh-based financial adviser accused of taking money without permission from the accounts of several professional athletes.
Walt Disney is scheduled to report its fiscal second-quarter financial results after the markets close on Tuesday.
SodaStream International reported blowout first-quarter financial results before the markets opened on Tuesday.
Rackspace Hosting, Inc. (NYSE: RAX) reported first-quarter financial results after the markets closed on Monday. The company had $0.37 in earnings per share (EPS) on $518 million in revenue compared to consensus estimates from…
Rackspace Hosting is scheduled to release its first-quarter financial results after the markets close on Monday.
Merus plans to offer more than 4 million shares within an expected price range of $14 to $16 per share in an initial public offering valued up to more than $79 million.
Argus has upgraded Altria to a Buy rating from Hold with a price target of $68, implying an upside of around 8%.
Theravance Biopharma has announced that the FDA approved its supplemental New Drug Application for Vibativ (telavancin) to expand the product's label.
Horizon Pharma reported better-than-expected first-quarter financial results before the markets opened on Monday.
When Yelp reported its first-quarter financial results on Thursday, it was not as bad as analysts initially estimated and this thrilled investors.
After FireEye reported its first-quarter financial results on Thursday, analysts piled into the stock, and a lot of them lowered their targets.
When Endo International reported its first-quarter financial results on Thursday, earnings vastly underwhelmed, and analysts definitely had something to say about it.
Although the markets have made their comeback from a weak first quarter, some stocks are still slowing that recovery and punishing their shareholders. 24/7 Wall St. has picked out some companies that punished shareholders…